Portal de investigação
Corrigendum: Evaluation of PIK3CA mutations in advanced ER+/HER2-breast cancer in Portugal – U-PIK Project(Front. Mol. Biosci., (2023), 10, (1082915), 10.3389/fmolb.2023.1082915)
Data de publicação:
Data Ahead of Print:
Autores da FMUP
Participantes de fora da FMUP
- Peixoto A.
- Cirnes L.
- Carvalho A.L.
- Andrade M.J.
- Maria Jose Brito
- Borralho P.
- Coimbra N.
- Borralho P.M.
- Carneiro A.S.
- Castro L.
- Correia L.
- Dionísio M.R.
- Faria C.
- Figueiredo P.
- Gomes A.
- Paixão J.
- Pinheiro M.
- Prazeres H.
- Ribeiro J.
- Salgueiro N.
- Silva F.
- Silvestre A.R.
- Sousa A.C.
- Almeida-Tavares J.
- Teixeira M.R.
- André S.
- Machado J.C.
Unidades de investigação
Abstract
In the published article, there was an error in the author list, and author Nuno Coimbra was erroneously excluded. The corrected author list appears below. Ana Peixoto1, Luís Cirnes2, Ana Luísa Carvalho3, Maria João Andrade4, Maria José Brito5, Paula Borralho6,7, Nuno Coimbra8, Pedro M. Borralho9, Ana Sofia Carneiro10, Lisandra Castro11, Lurdes Correia10,12, Maria Rita Dionísio9, Carlos Faria4, Paulo Figueiredo13, Ana Gomes4, Joana Paixão10, Manuela Pinheiro1, Hugo Prazeres13, Joana Ribeiro5, Natália Salgueiro11, Fernando C. Schmitt2,14, Fátima Silva4,15,16, Ana Rita Silvestre6, Ana Carla Sousa17, Joana Almeida-Tavares10, Manuel R. Teixeira1,18,*, Saudade André3,* and José Carlos Machado2,14,* Following this correction, the Author contributions section should also be corrected to include the contribution of author Nuno Coimbra as follows: “JCM, SA, MRT, and PMB conceived the U-PIK Project. JCM, SA, MRT, PMB, FCS, MJA, MJB, PB, MRD, HP, NS, ACS, JAT participated in the study design. AP, LCi, ALC, MJA, MJB, PB, NC, ASC, LCa, LCo, CF, PF, AG, JP, MP, HP, JR, NS, FCS, FS, ARS, ACS, JAT performed the experimental work involved in sample preparation, DNA extraction and PIK3CA testing and reporting. JCM, SA and MRT were responsible for analyzing PIK3CA testing data from U-PIK testers, for reporting anonymized PIK3CA testing performance back to U-PIK testers, and also for the analysis of molecular reports. JCM, SA, MRT, PMB and AP edited the manuscript, drafted and written with editorial assistance of JCS (Acknowledgements). All authors read and approved the final manuscript.” In the published article, there was an error regarding the affiliation for Nuno Coimbra, who was erroneously excluded from the author list and should have affiliation Serviço de Anatomia Patológica, Instituto Português de Oncologia do Porto Francisco Gentil (IPO Porto), Porto, Portugal. The authors apologize for these errors and state that these do not change the scientific conclusions of the article in any way. The original article has been updated. Copyright © 2024 Peixoto, Cirnes, Carvalho, Andrade, Maria José Brito, Borralho, Coimbra, Borralho, Carneiro, Castro, Correia, Dionísio, Faria, Figueiredo, Gomes, Paixão, Pinheiro, Prazeres, Ribeiro, Salgueiro, Schmitt, Silva, Silvestre, Sousa, Almeida-Tavares, Teixeira, André and Machado.
Copyright © 2024 Peixoto, Cirnes, Carvalho, Andrade, Maria José Brito, Borralho, Coimbra, Borralho, Carneiro, Castro, Correia, Dionísio, Faria, Figueiredo, Gomes, Paixão, Pinheiro, Prazeres, Ribeiro, Salgueiro, Schmitt, Silva, Silvestre, Sousa, Almeida-Tavares, Teixeira, André and Machado.
Dados da publicação
- ISSN/ISSNe:
- 2296-889X, 2296-889X
- Tipo:
- Correction
- Páginas:
- 1298522-1298522
- Link para outro recurso:
- www.scopus.com
Frontiers in Molecular Biosciences Frontiers Media S.A.
Documentos
- Não há documentos
Filiações
Keywords
- advanced breast cancer; ER+/HER2-; molecular pathology; PIK3CA mutations; ring trial; validation
Proyectos asociados
Parâmetros que demonstram ter influência na resposta à terapia neoadjuvante em pacientes com cancro da mama: Estado da arte e perspetivas futuras
Investigador Principal: Fernando Carlos de Landér Schmitt
Estudo Clínico Académico . 2021
Citar a publicação
Peixoto A,Cirnes L,Carvalho AL,Andrade MJ,Maria B,Borralho P,Coimbra N,Borralho PM,Carneiro AS,Castro L,Correia L,Dionísio MR,Faria C,Figueiredo P,Gomes A,Paixão J,Pinheiro M,Prazeres H,Ribeiro J,Salgueiro N,Schmitt FC,Silva F,Silvestre AR,Sousa AC,Almeida J,Teixeira MR,André S,Machado JC. Corrigendum: Evaluation of PIK3CA mutations in advanced ER+/HER2-breast cancer in Portugal – U-PIK Project(Front. Mol. Biosci., (2023), 10, (1082915), 10.3389/fmolb.2023.1082915). Front. Mol. Biosci. 2024. 11p. 1298522-1298522. IF:5,000. (2).
